ML-SI3

CAT:
804-HY-139426-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
ML-SI3 - image 1

ML-SI3

  • Description :

    ML-SI3 is a mixture of cis/trans ML-SI3 (HY-139426A), which is a TRPML1/2 channel inhibitor with IC50s of 4.7 μM and 1.7 μM, respectively. ML-SI3 also inhibits lysosomal calcium efflux and blocks downstream TRPML1-mediated autophagy. The cis/trans ML-SI3 (HY-139426A) components of ML-SI3 are TRPML2 activators with EC50s of 3.3 μM and 9.4 μM, respectively[1][2].
  • Product Name Alternative :

    ML-SI3 (cis/trans mix)
  • UNSPSC :

    12352005
  • Hazard Statement :

    H302, H315, H319, H335
  • Target :

    Parasite; TRP Channel
  • Type :

    Reference compound
  • Related Pathways :

    Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling
  • Applications :

    Neuroscience-Neuromodulation
  • Field of Research :

    Neurological Disease; Cardiovascular Disease
  • Assay Protocol :

    https://www.medchemexpress.com/ml-si3.html
  • Purity :

    99.93
  • Solubility :

    DMSO : 50 mg/mL (ultrasonic)
  • Smiles :

    O=S(C1=CC=CC=C1)(NC2C(N3CCN(C4=CC=CC=C4OC)CC3)CCCC2)=O
  • Molecular Formula :

    C23H31N3O3S
  • Molecular Weight :

    429.58
  • Precautions :

    H302, H315, H319, H335
  • References & Citations :

    [1]Rühl P, et al. Estradiol analogs attenuate autophagy, cell migration and invasion by direct and selective inhibition of TRPML1, independent of estrogen receptors. Sci Rep. 2021 Apr 15;11 (1) :8313. |[2]Kilpatrick BS, et al. Endo-lysosomal TRP mucolipin-1 channels trigger global ER Ca2+ release and Ca2+ influx. J Cell Sci. 2016 Oct 15;129 (20) :3859-3867. |[3]Bais S, et al. Schistosome TRPML channels play a role in neuromuscular activity and tegumental integrity. Biochimie. 2022 Mar;194:108-117. |[4]Zhang X, et al. Rapamycin directly activates lysosomal mucolipin TRP channels independent of mTOR. PLoS Biol. 2019 May 21;17 (5) :e3000252. |[5]Xing Y, et al. Blunting TRPML1 channels protects myocardial ischemia/reperfusion injury by restoring impaired cardiomyocyte autophagy. Basic Res Cardiol. 2022 Apr 7;117 (1) :20. |[6]Leser C, et al. Chemical and pharmacological characterization of the TRPML calcium channel blockers ML-SI1 and ML-SI3. Eur J Med Chem. 2021 Jan 15;210:112966.
  • Shipping Conditions :

    Room Temperature
  • Storage Conditions :

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category :

    Reference compound1
  • Clinical Information :

    No Development Reported
  • Isoform :

    Schistosome; TRPML1; TRPML2; TRPML3
  • CAS Number :

    [891016-02-7]

Featured Selection

Popular Products

Discover our most sought-after biotechnology products, trusted by researchers worldwide